Frost & Sullivan: Predictive Testing to Emerge as a Key Growth Area in European Genetic Testing and Screening Services Market

Frost & Sullivan: Predictive Testing to Emerge as a Key Growth Area in European Genetic Testing and Screening Services Market PR Newswire LONDON, July 18, 2012 - Despite growing demand, varied reimbursement and regulatory policies could impede market momentum LONDON, July 18, 2012 /PRNewswire/ -- The European genetic testing and screening services market is poised to be driven by the increasing availability of tests covering a wider range of disease areas, paralleled by a rapidly expanding pool of potential consumers. Testing for genetic diseases has swiftly moved from the laboratory into medical practice. In this process, issues related to quality have not received adequate attention. New analysis from Frost & Sullivan (http://www.drugdiscovery.frost.com), European Genetic Testing and Screening Services Market, finds that the market earned revenues of $896.2 million in 2011 and estimates this to reach $1,908.8 million in 2018. The research covers diagnostic testing/screening, relationship testing and predictive testing. Heightened awareness, primarily due to widespread genetic counselling groups and the availability of direct-to- consumer (DTC) tests will boost market prospects. "Demand for genetic testing will receive further impetus when accompanied by consultation, counselling physician's advice and proper reimbursement," noted Frost & Sullivan Senior Research Analyst Divyaa Ravishankar.